NEUROLOGY AND NEUROSURGERYFor the 11th straight year, Northwestern Memorial Hospital is proud to be ranked among the top 10 in the nation for neurology and neurosurgery by U.S. News & World Report, 2023 – 2024.
The health and well-being of patients is at the core of our department’s mission. We deliver on our mission by providing outstanding evidence-based clinical care and by developing new treatments and techniques through innovative research. Our program includes the Neuroradiology Department, which collaborates with the Northwestern Medicine Department of Radiology to interpret CT and MRI exams of the brain, head, neck and spine. Our Neuropathology Department specializes in diagnosing diseases of the nervous system, including degenerative diseases, tumors, infections, malformations and neuromuscular disorders. We balance our clinical work with training residents and fellows, tomorrow's leaders in medicine. Keep reading to learn more about our work. |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects with Parkinson’s Disease (Protocol #228PD201) |
Alliance A071401: Phase II Trial Of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas With SMO/AKT/NF2 Mutations |
A new Northwestern Medicine study published in Annals of Neurology examined the first 600 patients with long COVID-19 who were evaluated at the Northwestern Medicine Neuro COVID-19 Clinic. The study discovered that those initially hospitalized for acute COVID-19 pneumonia showed a broad pattern of cognitive impairment, while non-hospitalized long-haulers mainly had difficulties with attention tasks.
|
November 15, 2021 - November 15, 2024
Regenerative nanomedicine is being used to develop new therapies for devastating conditions such as severe spinal cord injuries. Northwestern's Dr. Samuel Stupp is a pioneer in the field of regenerative nanomedicine and recently published a paper in the journal Science that details how a new injectable therapy uses synthetic nanofibers to reverse severe spinal cord injuries in animals and how this therapy could soon be used in humans. |
Thursday, February 25, 2021, 5:00 PM - Friday, February 25, 2022, 7:00 PM
Covers the current understanding of the role of the lysosomal pathway in pathogenesis of sporadic and genetic forms of PD, review the genetically targeted clinical trials and discuss mechanisms for genotyping of PD patients, as well as the role of genetic counseling. |
Meet Our Neurosciences Faculty at Northwestern University Feinberg School of MedicineWe are committed to improving human health through education and discovery. NEURORADIOLOGY FACULTY NEUROPATHOLOGY FACULTY |
About Us Terms of Use Privacy Policy
© 2023 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |
Connect with us
breakthroughsforphysicians@nm.org International physicians, contact international@nm.org |